Yahoo India Web Search

Search results

  1. Burjeel Holdings operates various brands of hospitals and clinics across the UAE, offering quality and specialized healthcare services. Learn more about its latest news, accreditations, and core expertise in orthopaedic care.

    • Investor Relations

      Founded in 2007, Burjeel Holdings is one of the leading...

    • Results and Reports

      Burjeel Holdings Announces Record Financial Results:...

    • Careers

      Burjeel Holdings combines world-class healthcare with the...

    • About Us

      Founded in 2007 by Dr. Shamsheer Vayalil, Burjeel Holdings...

    • Contact

      We’re here to help. You can get in touch with us by email,...

    • News & Media

      Burjeel Holdings and UAE Ministry of Climate Change and...

    • International Patients

      Our International Patients team provides a comprehensive...

    • Investment Case

      Burjeel Holdings is a leading private healthcare services...

  2. Burjeel is a premium healthcare brand under Burjeel Holdings, offering state-of-the-art facilities and in-depth expertise in various specialties. Learn about Burjeel's vision, mission, values, leadership, and specialties on their website.

  3. Burjeel Holdings. 86,612 followers. 2d. Unveiling AL KALMA, our groundbreaking joint venture with Colombia-based Keralty. We are on a mission to deliver personalized care while reducing...

  4. Burjeel Holdings is a new intermediary holding company launched by VPS Healthcare, a leading UAE-based private healthcare services platform. It aims to consolidate its healthcare offerings in the UAE, Oman, and across the GCC, and to support humanitarian initiatives such as pediatric stem cell transplantations for refugees.

  5. Feb 10, 2023 · Burjeel Holdings delivers record FY22 results with net profit up 52% to AED 355 million. IPO proceeds of AED2.2bn drives net debt reduction to AED1.1bn. Revenue of AED 3.92 billion up 17% y-o-y with EBITDA of AED 878 million up 13%. Strong financial position with Net Debt/EBITDA* at 1.5x at the end of the period.